--- title: "Planet 13 Holdings Inc. (PLNH.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/PLNH.US.md" symbol: "PLNH.US" name: "Planet 13 Holdings Inc." industry: "Pharmaceuticals" --- # Planet 13 Holdings Inc. (PLNH.US) | Item | Detail | |------|--------| | Industry | Pharmaceuticals | | Location | US Market | | Website | [www.planet13.com](https://www.planet13.com) | ## Company Profile Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. It owns, manufactures, and sells cannabis products in the form of gummies and beverages, chocolates, vapes and concent... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-23T04:30:15.000Z **Overall: D (0.68)** **Industry**: Pharmaceuticals | Metric | Value | |--------|-------| | Industry Ranking | 151 / 190 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -0.60% | | | Net Profit YoY | -140.74% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.97 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 52.74M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 108.44M | | **Multi Score**: D #### Profit Score: E | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -83.55% | E | | Profit Margin | -79.07% | E | | Gross Margin | 21.31% | D | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -0.60% | D | | Net Profit YoY | -140.74% | E | | Total Assets YoY | -34.76% | E | | Net Assets YoY | -63.77% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -126.47% | D | | OCF YoY | -0.60% | D | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.54 | C | #### Debt Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 65.56% | D | ```chart-data:radar { "title": "Longbridge Financial Score - Planet 13 Holdings Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "E", "indicators": [ { "name": "ROE", "value": "-83.55%", "rating": "E" }, { "name": "Profit Margin", "value": "-79.07%", "rating": "E" }, { "name": "Gross Margin", "value": "21.31%", "rating": "D" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-0.60%", "rating": "D" }, { "name": "Net Profit YoY", "value": "-140.74%", "rating": "E" }, { "name": "Total Assets YoY", "value": "-34.76%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-63.77%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-126.47%", "rating": "D" }, { "name": "OCF YoY", "value": "-0.60%", "rating": "D" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.54", "rating": "C" } ] }, { "name": "Security", "grade": "D", "indicators": [ { "name": "Gearing Ratio", "value": "65.56%", "rating": "D" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Eli Lilly (US.LLY) | A | A | B | E | B | B | | 02 | ROCHE HOLDINGS AG (US.RHHVF) | A | B | B | D | C | B | | 03 | Roche (US.RHHBY) | A | B | B | D | C | B | | 04 | AstraZeneca (US.AZN) | A | B | C | D | C | B | | 05 | NOVARTIS AG (US.NVS) | A | B | C | D | C | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.62 | 94/257 | - | - | - | | PB | 0.97 | 43/257 | 1.03 | 0.75 | 0.63 | | PS (TTM) | 0.49 | 17/257 | 0.74 | 0.60 | 0.53 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/PLNH.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/PLNH.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/PLNH.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.